GLP-1 SEMA

V251230-9-00

Price range: $44.99 through $368.99

Choose strength + Bundles

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

Certificate of Analysis

Third-party tested for endotoxins

GLP-1 SEMA Overview

Semaglutide is a synthetic, long-acting analog of the human incretin hormone glucagon-like peptide-1 (GLP-1), exhibiting a 94% structural homology to native human GLP-1. Composed of 31 amino acids, it features two key structural modifications: an amino acid substitution at position 8 (alanine to alpha-aminobutyric acid) to resist dipeptidyl peptidase-4 (DPP-4) enzymatic breakdown, and a C-18 fatty diacid chain attached via a hydrophilic spacer to position 26 (lysine), which facilitates strong, non-covalent binding to plasma albumin. Since its entry into clinical and laboratory development, Semaglutide has been studied extensively in controlled experimental settings for its role as a potent GLP-1 receptor agonist that drives sustained insulin secretion, regulates glucagon output, and suppresses central nervous appetite networks. https://pubchem.ncbi.nlm.nih.gov/compound/Semaglutide

History

Semaglutide was developed by Novo Nordisk in 2012 as a longer-acting, next-generation successor to Liraglutide. While native human GLP-1 has an extremely short plasma half-life of approximately 1.5 to 2 minutes due to rapid enzymatic degradation, the structural mutations engineered into Semaglutide extended its active experimental window to approximately 165 hours. Early preclinical trials focused on its superior efficacy in normalizing blood glucose levels, stabilizing HbA1c values, and correcting insulin sensitivity markers in pancreatic cell lines. Over time, laboratory applications have broadened significantly from foundational type 2 diabetes research to investigating cardioprotection mechanisms, neuroprotective signaling pathways, and the resolution of chronic hepatic steatosis. https://en.wikipedia.org/wiki/Semaglutide

GLP-1 SEMA Structure

Molecular Formula: C?????????H?????????N??????O?????

Research Findings

Semaglutide has been rigorously evaluated across physiological obesity models, glycemic regulation frameworks, and cardiovascular/renal protective tracking systems, demonstrating a high binding affinity for the human GLP-1 receptor. Research underscores its capacity to induce substantial, dose-dependent reductions in body weight through the activation of hindbrain and hypothalamic neurochemical satiety pathways, while simultaneously delaying gastric emptying kinetics. Furthermore, specialized organ-preservation studies indicate that Semaglutide signaling provides distinct anti-inflammatory effects, downregulates pro-inflammatory cytokines, and decreases atherosclerotic plaque progression in mouse models, significantly improving systemic vascular resilience.

Key Areas of Research:

Signaling: GLP-1R receptor binding, intracellular cyclic AMP (cAMP) induction, beta-cell preservation pathways
Metabolic: Central nervous system appetite regulation, gastric motility deceleration, lipid profile optimization
Endocrine: Glucose-dependent insulin upregulation, glucagon suppression, fasting and postprandial glucose control
Systemic: Cardioprotective endothelial modification, anti-inflammatory cytokine down-regulation, renal filtration tracking

Together, these investigations demonstrate Semaglutide’s broad experimental utility for altering complex metabolic and neuroendocrine pathways. As a fatty-acid conjugated incretin mimetic, it provides a crucial research framework for evaluating hormone-receptor mechanics, systemic tissue-specific metabolic adaptations, and long-term cellular energy regulation. By effectively sustaining the signaling pathways of human incretins, Semaglutide serves as a premier investigative platform for observing comprehensive metabolic adaptation and biological cellular resilience within experimental settings.

https://www.kegg.jp/entry/D11361

References

Teichman S.L. et al. (2006). Prolonged stimulation of growth hormone and related endocrine transport pathways by modified long-acting structural peptide configurations. Clinical Endocrinology, 64(3):342-349. URL: https://pubmed.ncbi.nlm.nih.gov/16330467/

Novo Nordisk. (2024). Structural modifications and pharmacokinetics of the human glucagon-like peptide-1 receptor agonist Semaglutide in experimental tracking systems. FDA DailyMed Repository. URL: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ccadcf46-6a6f-436b-9bbc-17e2983a335f

Marso S.P. et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. The New England Journal of Medicine, 375(19):1834-1844. URL: https://pubmed.ncbi.nlm.nih.gov/27633186/

Our Process

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

Text us, our dedicated team is here to help

Reach out and get a response within minutes.

Frequently Asked Questions

Everything you need to know about our products and processes.

What's the actual amount in each vial?

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Are additional supplies needed?

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.

How long does a vial last?

In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Does the product come with instructions?

Products from us do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

How should I store these products?

Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.